Conflict of interests for radiation oncologists: Harnessing disclosures from policy to reality

Reames, 2013, Critical evaluation of oncology clinical practice guidelines, J Clin Oncol, 31, 2563, 10.1200/JCO.2012.46.8371 Kesselheim, 2012, Conflict of interests reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures, PLoS Med, 9, e1001280, 10.1371/journal.pmed.1001280 Rothman, 2009, Professional medical associations and their relationships with industry: a proposal for controlling conflict of interests, JAMA, 301, 1367, 10.1001/jama.2009.407 De Gara, 2013, Perceptions of conflict of interests: surgeons, internists, and learners compared, Am J Surg, 205, 541, 10.1016/j.amjsurg.2013.01.012 Ancker, 2007, A comparison of conflict of interests policies at peer-reviewed journals in different scientific disciplines, Sci Eng Ethics, 13, 147, 10.1007/s11948-007-9011-z Blum, 2009, Requirements and definitions in conflict of interests policies of medical journals, JAMA, 302, 2230, 10.1001/jama.2009.1669 Saito, 2010, Japanese practicing physicians’ relationships with pharmaceutical representatives: a national survey, PloS One, 5, e12193, 10.1371/journal.pone.0012193 Irwin, 2012, Conflict of interests disclosure in off-label oncology clinical trials, J Oncol Pract Am Soc Clin Oncol, 8, 298, 10.1200/JOP.2011.000523 Kesselheim, 2012, Conflict of interests in oncology publications: a survey of disclosure policies and statements, Cancer, 118, 188, 10.1002/cncr.26237 Lockhart, 2013, Physician and stakeholder perceptions of conflict of interests policies in oncology, J Clin Oncol, 31, 1677, 10.1200/JCO.2012.47.5475 Glatstein, 2010, Distinguishing “controversy” from conflict of interests: the wrong image for radiation oncology, Int J Radiat Oncol Biol Phys, 76, 1283, 10.1016/j.ijrobp.2009.09.076 Goffman, 2004, The vulnerability of radiation oncology within the medical industrial complex, Int J Radiat Oncol Biol Phys, 59, 1, 10.1016/j.ijrobp.2003.12.026 Djulbegovic, 2007, The sound and the fury: financial conflicts of interests in oncology, J Clin Oncol, 25, 3567, 10.1200/JCO.2007.11.9800 Halperin, 2004, A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers, Int J Radiat Oncol Biol Phys, 59, 1477, 10.1016/j.ijrobp.2004.01.052 Sollitto, 2003, Intrinsic conflicts of interests in clinical research: a need for disclosure, Kennedy Inst Ethics J, 13, 83, 10.1353/ken.2003.0015 American Society of Clinical Oncology, 2014, The changing landscape of conflict of interests supports further study of American Society of Clinical Oncology authorship restrictions for research studies, J Clin Oncol, 32, 867, 10.1200/JCO.2014.55.4006 Brierley, 2013, Conflicts of interests in editorials in high-impact journals, J Clin Oncol, 31, 4375, 10.1200/JCO.2013.52.9669 Johnson, 2013, industry sponsorship, and integrity in cancer research reporting, J Clin Oncol, 31, 2243, 10.1200/JCO.2013.48.8817 American Society of Clinical Oncology, 2013, American Society of Clinical Oncology policy for relationships with companies: background and rationale, J Clin Oncol, 31, 2037, 10.1200/JCO.2013.49.4997 Go, 2008, Disclosure of financial conflicts of interests by authors publishing in the Journal of Clinical Oncology, J Clin Oncol, 26, 509, 10.1200/JCO.2007.15.0490 Riechelmann, 2007, Disclosure of conflicts of interests by authors of clinical trials and editorials in oncology, J Clin Oncol, 25, 4642, 10.1200/JCO.2007.11.2482 Parascandola, 2007, A turning point for conflicts of interest: the controversy over the National Academy of Sciences’ first conflicts of interests disclosure policy, J Clin Oncol, 25, 3774, 10.1200/JCO.2006.09.2890 Hampson, 2007, Frequency, type, and monetary value of financial conflicts of interests in cancer clinical research, J Clin Oncol, 25, 3609, 10.1200/JCO.2006.09.3633 American Society of Clinical Oncology, 2006, Revisions of and clarifications to the ASCO conflict of interest's policy, J Clin Oncol, 24, 517, 10.1200/JCO.2005.04.8918 Bariani, 2013, Self-reported conflicts of interests of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology, J Clin Oncol, 31, 2289, 10.1200/JCO.2012.46.6706 Valachis, 2012, Financial relationships in economic analyses of targeted therapies in oncology, J Clin Oncol, 30, 1316, 10.1200/JCO.2011.38.6078 Rose, 2010, Relationships between authorship contributions and authors’ industry financial ties among oncology clinical trials, J Clin Oncol, 28, 1316, 10.1200/JCO.2008.21.6606 Berlin, 2007, Ethics in oncology: consulting for the investment industry, J Clin Oncol, 25, 444, 10.1200/JCO.2006.10.3036 Smith, 1995, Ethical considerations in oncology: balancing the interests of patients, oncologists, and society, J Clin Oncol, 13, 2464, 10.1200/JCO.1995.13.9.2464